Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Detection and functional analysis of CD8+ T cells specific for PRAME: a target for T-cell therapy.

Griffioen M, Kessler JH, Borghi M, van Soest RA, van der Minne CE, Nouta J, van der Burg SH, Medema JP, Schrier PI, Falkenburg JH, Osanto S, Melief CJ.

Clin Cancer Res. 2006 May 15;12(10):3130-6.

2.

Expression and function of the apoptosis effector Apaf-1 in melanoma.

Peltenburg LT, de Bruin EC, Meersma D, Smit NP, Schrier PI, Medema JP.

Cell Death Differ. 2005 Jun;12(6):678-9. No abstract available.

3.

c-Myc is able to sensitize human melanoma cells to diverse apoptotic triggers.

Peltenburg LT, de Bruin EC, Meersma D, Wilting S, Jürgensmeier JM, Schrier PI.

Melanoma Res. 2004 Feb;14(1):3-12.

PMID:
15091188
4.

Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates.

Griffioen M, Borghi M, Schrier PI, Osanto S, Schadendorf D.

Cancer Immunol Immunother. 2004 Aug;53(8):715-22. Epub 2004 Mar 3.

PMID:
14997347
5.

High intrinsic apoptosis, but not radiation-induced apoptosis, predicts better survival in rectal carcinoma patients.

Marijnen CA, Nagtegaal ID, Mulder-Stapel AA, Schrier PI, van de Velde CJ, van Krieken JH, Peltenburg LT.

Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):434-43.

PMID:
12957255
6.

CD4+ Th2 cell recognition of HLA-DR-restricted epitopes derived from CAMEL: a tumor antigen translated in an alternative open reading frame.

Slager EH, Borghi M, van der Minne CE, Aarnoudse CA, Havenga MJ, Schrier PI, Osanto S, Griffioen M.

J Immunol. 2003 Feb 1;170(3):1490-7.

7.

Stretch-induced paracrine hypertrophic stimuli increase TGF-beta1 expression in cardiomyocytes.

van Wamel AJ, Ruwhof C, van der Valk-Kokshoorn LJ, Schrier PI, van der Laarse A.

Mol Cell Biochem. 2002 Jul;236(1-2):147-53.

PMID:
12190114
8.

TCR reconstitution in Jurkat reporter cells facilitates the identification of novel tumor antigens by cDNA expression cloning.

Aarnoudse CA, Krüse M, Konopitzky R, Brouwenstijn N, Schrier PI.

Int J Cancer. 2002 May 1;99(1):7-13.

9.

p53 expression in human rectal tissue after radiotherapy: upregulation in normal mucosa versus functional loss in rectal carcinomas.

Marijnen CA, Kapiteijn E, Nagtegaal ID, Mulder-Stapel AA, van de Velde CJ, Schrier PI, Peltenburg LT, van Krieken JH.

Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):720-8.

PMID:
11849795
10.
11.

Direct, autocrine and paracrine effects of cyclic stretch on growth of myocytes and fibroblasts isolated from neonatal rat ventricles.

Ruwhof C, van Wamel AE, van der Valk LJ, Schrier PI, van der Laarse A.

Arch Physiol Biochem. 2001 Feb;109(1):10-7.

PMID:
11471066
12.

The role of angiotensin II, endothelin-1 and transforming growth factor-beta as autocrine/paracrine mediators of stretch-induced cardiomyocyte hypertrophy.

van Wamel AJ, Ruwhof C, van der Valk-Kokshoom LE, Schrier PI, van der Laarse A.

Mol Cell Biochem. 2001 Feb;218(1-2):113-24.

PMID:
11330825
13.
14.

Rapid effects of stretched myocardial and vascular cells on gene expression of neonatal rat cardiomyocytes with emphasis on autocrine and paracrine mechanisms.

van Wamel AJ, Ruwhof C, van der Valk-Kokshoorn LJ, Schrier PI, van der Laarse A.

Arch Biochem Biophys. 2000 Sep 1;381(1):67-73.

PMID:
11019821
15.

Retargeting of a T cell line by anti MAGE-3/HLA-A2 alpha beta TCR gene transfer.

Calogero A, Hospers GA, Krüse KM, Schrier PI, Mulder NH, Hooijberg E, de Leij LF.

Anticancer Res. 2000 May-Jun;20(3A):1793-9.

PMID:
10928109
16.

Rapid gene transcription induced by stretch in cardiac myocytes and fibroblasts and their paracrine influence on stationary myocytes and fibroblasts.

van Wamel JE, Ruwhof C, van der Valk-Kokshoorn EJ, Schrier PI, van der Laarse A.

Pflugers Arch. 2000 Apr;439(6):781-8.

PMID:
10784353
17.

The influence of the oncogene N-ras on cell cycle delay in a human melanoma cell line with reduced radioresistance.

Pomp J, Ouwerkerk IJ, Hoogstraten C, Wondergem J, Davelaar J, Leer JW, Schrier PI.

Oncol Rep. 2000 May-Jun;7(3):663-7.

PMID:
10767387
18.

Vaccination of melanoma patients with an allogeneic, genetically modified interleukin 2-producing melanoma cell line.

Osanto S, Schiphorst PP, Weijl NI, Dijkstra N, Van Wees A, Brouwenstein N, Vaessen N, Van Krieken JH, Hermans J, Cleton FJ, Schrier PI.

Hum Gene Ther. 2000 Mar 20;11(5):739-50.

PMID:
10757353
19.

Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-1.

Aarnoudse CA, van den Doel PB, Heemskerk B, Schrier PI.

Int J Cancer. 1999 Jul 30;82(3):442-8.

20.

Influence of increased c-Myc expression on the growth characteristics of human melanoma.

Schlagbauer-Wadl H, Griffioen M, van Elsas A, Schrier PI, Pustelnik T, Eichler HG, Wolff K, Pehamberger H, Jansen B.

J Invest Dermatol. 1999 Mar;112(3):332-6.

21.

Role of the interferon-stimulated response element in HLA-B downregulation in human melanoma cell lines.

Griffioen M, Ouwerkerk IJ, Harten V, Gobin SJ, van den Elsen PJ, Schrier PI.

Immunogenetics. 1999 Apr;49(4):287-94.

PMID:
10079292
22.

p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis.

Zerp SF, van Elsas A, Peltenburg LT, Schrier PI.

Br J Cancer. 1999 Feb;79(5-6):921-6.

23.

HLA-B down-regulation in human melanoma is mediated by sequences located downstream of the transcription-initiation site.

Griffioen M, Ouwerkerk IJ, Harten V, Schrier PI.

Int J Cancer. 1999 Feb 9;80(4):573-80.

24.

Repression of the minimal HLA-B promoter by c-myc and p53 occurs through independent mechanisms.

Griffioen M, Steegenga WT, Ouwerkerk IJ, Peltenburg LT, Jochemsen AG, Schrier PI.

Mol Immunol. 1998 Sep;35(13):829-35.

PMID:
9839551
25.

Definition of unique and shared T-cell defined tumor antigens in human renal cell carcinoma.

Brouwenstijn N, Hoogstraten C, Verdegaal EM, Van der Spek CW, Deckers JG, Mulder A, Osanto S, Schrier PI.

J Immunother. 1998 Nov;21(6):427-34.

PMID:
9807737
26.

Expression of MAGE, gp100 and tyrosinase genes in uveal melanoma cell lines.

Luyten GP, van der Spek CW, Brand I, Sintnicolaas K, de Waard-Siebinga I, Jager MJ, de Jong PT, Schrier PI, Luider TM.

Melanoma Res. 1998 Feb;8(1):11-6.

PMID:
9508371
27.

Identification of HLA-A*0201-restricted CTL epitopes encoded by the tumor-specific MAGE-2 gene product.

Visseren MJ, van der Burg SH, van der Voort EI, Brandt RM, Schrier PI, van der Bruggen P, Boon T, Melief CJ, Kast WM.

Int J Cancer. 1997 Sep 26;73(1):125-30.

28.

Transfection of IL-2 augments CTL response to human melanoma cells in vitro: immunological characterization of a melanoma vaccine.

van Elsas A, Aarnoudse C, van der Minne CE, van der Spek CW, Brouwenstijn N, Osanto S, Schrier PI.

J Immunother. 1997 Sep;20(5):343-53.

PMID:
9336741
29.

UV-induced N-ras mutations are T-cell targets in human melanoma.

van Elsas A, Scheibenbogen C, van der Minne C, Zerp SF, Keilholz U, Schrier PI.

Melanoma Res. 1997 Aug;7 Suppl 2:S107-13. Review.

PMID:
9578425
30.

Activated N-ras contributes to the chemoresistance of human melanoma in severe combined immunodeficiency (SCID) mice by blocking apoptosis.

Jansen B, Schlagbauer-Wadl H, Eichler HG, Wolff K, van Elsas A, Schrier PI, Pehamberger H.

Cancer Res. 1997 Feb 1;57(3):362-5.

31.

Transcription of the gene encoding melanoma-associated antigen gp100 in tissues and cell lines other than those of the melanocytic lineage.

Brouwenstijn N, Slager EH, Bakker AB, Schreurs MW, Van der Spek CW, Adema GJ, Schrier PI, Figdor CG.

Br J Cancer. 1997;76(12):1562-6.

32.

Inverse correlation between expression of HLA-B and c-myc in uveal melanoma.

Blom DJ, Mooy CM, Luyten GP, Kerkvliet S, Ouwerkerk I, Zwinderman AH, Schrier PI, Jager MJ.

J Pathol. 1997 Jan;181(1):75-9.

PMID:
9072006
33.

Renal-cell carcinoma-specific lysis by cytotoxic T-lymphocyte clones isolated from peripheral blood lymphocytes and tumor-infiltrating lymphocytes.

Brouwenstijn N, Gaugler B, Krüse KM, van der Spek CW, Mulder A, Osanto S, van den Eynde BJ, Schrier PI.

Int J Cancer. 1996 Oct 9;68(2):177-82.

34.

The influence of the oncogenes NRAS and MYC on the radiation sensitivity of cells of a human melanoma cell line.

Pomp J, Ouwerkerk IJ, Hermans J, Wondergem J, Cornelisse CJ, Leer JW, Schrier PI.

Radiat Res. 1996 Oct;146(4):374-81.

PMID:
8927709
35.

N-ras oncogene expression changes the growth characteristics of human melanoma in two independent SCID-hu mouse models.

Jansen B, Inoue SA, Wadl H, Eichler HG, Wolff K, Van Elsas A, Schrier PI, Pehamberger H.

Int J Cancer. 1996 Sep 17;67(6):821-5.

36.

Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma.

van Elsas A, Zerp SF, van der Flier S, Krüse KM, Aarnoudse C, Hayward NK, Ruiter DJ, Schrier PI.

Am J Pathol. 1996 Sep;149(3):883-93.

37.

Cell density dependent plating efficiency affects outcome and interpretation of colony forming assays.

Pomp J, Wike JL, Ouwerkerk IJ, Hoogstraten C, Davelaar J, Schrier PI, Leer JW, Thames HD, Brock WA.

Radiother Oncol. 1996 Aug;40(2):121-5.

PMID:
8884965
38.

Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen.

van Elsas A, van der Burg SH, van der Minne CE, Borghi M, Mourer JS, Melief CJ, Schrier PI.

Eur J Immunol. 1996 Aug;26(8):1683-9.

PMID:
8765006
39.

Establishment and characterization of an uveal-melanoma cell line.

De Waard-Siebinga I, Blom DJ, Griffioen M, Schrier PI, Hoogendoorn E, Beverstock G, Danen EH, Jager MJ.

Int J Cancer. 1995 Jul 17;62(2):155-61.

PMID:
7622289
40.

C-myc represses transiently transfected HLA class I promoter sequences not locus-specifically.

Griffioen M, Peltenburg LT, van Oorschot DA, Schrier PI.

Immunobiology. 1995 Jul;193(2-4):238-47.

PMID:
8530149
41.

Induction and characterization of cytotoxic T-lymphocytes recognizing a mutated p21ras peptide presented by HLA-A*0201.

Van Elsas A, Nijman HW, Van der Minne CE, Mourer JS, Kast WM, Melief CJ, Schrier PI.

Int J Cancer. 1995 May 4;61(3):389-96.

PMID:
7729952
42.

CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells.

Visseren MJ, van Elsas A, van der Voort EI, Ressing ME, Kast WM, Schrier PI, Melief CJ.

J Immunol. 1995 Apr 15;154(8):3991-8.

PMID:
7706738
43.

ras oncogene activation does not induce sensitivity to natural killer cell-mediated lysis in human melanoma.

van Elsas A, van Deursen E, Wielders R, van den Berg-Bakker CA, Schrier PI.

J Invest Dermatol. 1994 Nov;103(5 Suppl):117S-121S.

PMID:
7963672
44.

Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro.

Krasagakis K, Garbe C, Schrier PI, Orfanos CE.

Anticancer Res. 1994 Nov-Dec;14(6B):2565-71.

PMID:
7872682
45.

Human ovarian tumors of epithelial origin express PDGF in vitro and in vivo.

Versnel MA, Haarbrink M, Langerak AW, de Laat PA, Hagemeijer A, van der Kwast TH, van den Berg-Bakker LA, Schrier PI.

Cancer Genet Cytogenet. 1994 Mar;73(1):60-4.

PMID:
8174076
46.
47.

Activation of the mas oncogene involves coupling to human alphoid sequences.

van 't Veer LJ, van der Feltz MJ, van den Berg-Bakker CA, Cheng NC, Hermens RP, van Oorschot DA, Kievits T, Schrier PI.

Oncogene. 1993 Oct;8(10):2673-81.

PMID:
8378079
48.

Immunization with interleukin-2 transfected melanoma cells. A phase I-II study in patients with metastatic melanoma.

Osanto S, Brouwenstÿn N, Vaessen N, Figdor CG, Melief CJ, Schrier PI.

Hum Gene Ther. 1993 Jun;4(3):323-30.

PMID:
8338879
49.

Downregulation of HLA class I expression by c-myc in human melanoma is independent of enhancer A.

Peltenburg LT, Dee R, Schrier PI.

Nucleic Acids Res. 1993 Mar 11;21(5):1179-85.

50.

Establishment and characterization of 7 ovarian carcinoma cell lines and one granulosa tumor cell line: growth features and cytogenetics.

van den Berg-Bakker CA, Hagemeijer A, Franken-Postma EM, Smit VT, Kuppen PJ, van Ravenswaay Claasen HH, Cornelisse CJ, Schrier PI.

Int J Cancer. 1993 Feb 20;53(4):613-20.

PMID:
8436435

Supplemental Content

Loading ...
Support Center